Havens Advisors’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Havens Advisors’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-30,000	Closed	-$2.26M	–	52
2022 Q2	$2.26M	Buy	+30,000	New	+$1.33M	3.57%	11

Havens Advisors's TPTX Position: Q3 2022 in Review

Havens Advisors sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 30,000 shares — an estimated $2.26M sold.

Havens Advisors first reported a position in TPTX in Q2 2022 and held it in 1 quarter. The position peaked at $2.26M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Havens Advisors reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Havens Advisors sold 30,000 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $2.26M.
Havens Advisors first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Havens Advisors's Turning Point Therapeutics, Inc. Common Stock position peaked at $2.26M in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Havens Advisors's 13F filing for Q3 2022, filed 12 Oct 2022.